Sedative/hypnotic drug prescriptions
Walker, N.
New Zealand Medical Journal 97(754): 273
1984
ISSN/ISBN: 0028-8446 PMID: 6587215 Document Number: 224201
Document emailed within 1 workday
Related Documents
Jurna, I. 1976: Sedative and hypnotic drug effect Deutsche Medizinische Wochenschrift 101(51): 1893-1894De Fiebre, N.C.; Marley, R.J.; Wehner, J.M.; Collins, A.C. 1992: Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice Journal of Pharmacology and Experimental Therapeutics 263(1): 232-240
Cranwell-Bruce, L.A. 2007: Hypnotic sedative drugs Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 16(3): 198-200
Leslie, S.W. 1985: Sedative-hypnotic drugs: interaction with calcium channels Alcohol and Drug Research 6(6): 371-377
Villani, P.; Morciano, C.; Ambrosi, P.; Brondino-Riquier, R.; Bertault-Peres, P.; Penot-Ragon, C.; Bouvenot, G. 2001: Prescriptions and consumption of hypnotic and anxiolytic drugs in the South University Hospital of Marseille Therapie 56(1): 11-14
Feldmeier, H.; Spangenberg, K.; Egger, M.; Heinrich, H. 1981: Analysis of drug prescriptions--the possibility of determining the justification of prescriptions and patient compliance Zeitschrift für Arztliche Fortbildung 75(18): 854-855
Springer, V.; Kisska, I.; Hrcková, M. 2002: Drug policy in Slovakia and its reflection in prescriptions. 1. Prescriptions for mass-produced drugs according to physician specialty Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 51(3): 129-133
Koch, H.; Stockinger, L. 1971: Teratologic study on 3-(1,4-endoxo-cyclohexane-2-exo-3-exodicarboximido)-piperidine-2,6-dione (K2604), another compound with sedative-hypnotic activity and structural relation to thalidomide Arzneimittel-Forschung 21(12): 2022-2025
Gardulf, A.; Bergman, U.; George, C.; Nordström, G. 2005: Computerize drug handling! Scrutiny of drug prescriptions at four emergency hospitals show big shortages Lakartidningen 102(22): 1732-1734; 1736-1737
Merlo, J.; Liedholm, H.; Lindblad, U.; Fält, J.ür.; Lindberg, G.; Melander, A. 2002: Better drug management can improve public health--a study of possible drug interactions by scrutinizing prescriptions dispensing by pharmacies Lakartidningen 99(9): 922-925
Neuhaus, T. 1976: BP 400. A new sedative drug for pediatric patients Schweizerische Rundschau für Medizin Praxis 65(51): 1603-1610
Meng, Q.-Y.; Huang, H.-M.; Xu, H. 2019: The sedative effect of dexmedetomidine in outpatient undergoing dental surgery compared to several sedative drugs:a meta analysis Shanghai Kou Qiang Yi Xue 28(1): 100-109
Agrest, A. 1996: Drug prescriptions Medicina 56(2): 204-205
Teichner, H. 1977: Problems in the economy of drug prescriptions Fortschritte der Medizin 95(12): 757-758; 788
Rane, A. 2006: Drug committees should not recommend "off label" prescriptions Lakartidningen 103(15-16): 1219
Kreck, C.; Saller, R. 1995: Expert evaluation of private drug prescriptions Gesundheitswesen 57(5): 258-263
Robinson, D.S. 1984: Adverse reactions, toxicities, and drug interactions of newer antidepressants: anticholinergic, sedative, and other side effects Psychopharmacology Bulletin 20(2): 280-290
Davoudian, M.-L. 2010: Planning drug prescriptions in digestive system surgery Revue de l'Infirmiere 160: 41-42
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
Jämes, D.; Haller, E.; Rosselet, G.; Brooke, E.M.; Schelling, J.L. 1978: Frequency of drug prescriptions and their adverse effects in a medical department Schweizerische Medizinische Wochenschrift 108(33): 1270-1277